In her latest study, Rachel Perry, PhD, of Yale School of Medicine, reveals one of the clearest mechanisms to date behind a question patients often ask: Why
I vaguely remember that it depends on the cancer type whether that works. The study showed it for melonomas and breast cancer so for those there’s a good reason to decrease blood sugar or even doing a keto diet. I’d love to see further research on putting mice with melonomas on a keto diet.
Seyfried’s metabolic framework for cancer would indicate all cancer can only metabolize glucose. Ongoing studies in human’s right now with Seyfried’s press-pulse protocol on glioblastomas (aggressive standard of care only has a 6 month lifespan, so we will see results fairly quickly).
I vaguely remember that it depends on the cancer type whether that works. The study showed it for melonomas and breast cancer so for those there’s a good reason to decrease blood sugar or even doing a keto diet. I’d love to see further research on putting mice with melonomas on a keto diet.
Seyfried’s metabolic framework for cancer would indicate all cancer can only metabolize glucose. Ongoing studies in human’s right now with Seyfried’s press-pulse protocol on glioblastomas (aggressive standard of care only has a 6 month lifespan, so we will see results fairly quickly).